Cardlytics Ev To Operating Cash Flow vs Invested Capital Analysis

CDLX Stock

USD 8.89 0.35 3.79%

Cardlytics financial indicator trend analysis is way more than just evaluating Cardlytics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cardlytics is a good investment. Please check the relationship between Cardlytics Ev To Operating Cash Flow and its Invested Capital accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

Ev To Operating Cash Flow vs Invested Capital

Ev To Operating Cash Flow vs Invested Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cardlytics Ev To Operating Cash Flow account and Invested Capital. At this time, the significance of the direction appears to have pay attention.

The correlation between Cardlytics' Ev To Operating Cash Flow and Invested Capital is -0.82. Overlapping area represents the amount of variation of Ev To Operating Cash Flow that can explain the historical movement of Invested Capital in the same time period over historical financial statements of Cardlytics, assuming nothing else is changed. The correlation between historical values of Cardlytics' Ev To Operating Cash Flow and Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Operating Cash Flow of Cardlytics are associated (or correlated) with its Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Invested Capital has no effect on the direction of Ev To Operating Cash Flow i.e., Cardlytics' Ev To Operating Cash Flow and Invested Capital go up and down completely randomly.

Correlation Coefficient

-0.82

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Ev To Operating Cash Flow

A valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows.

Invested Capital

Invested capital represents the total cash investment that shareholders and debt holders have contributed to Cardlytics. There are two different methods for calculating Cardlytics invested capital: operating approach and financing approach. Understanding Cardlytics invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.

Most indicators from Cardlytics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cardlytics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.Tax Provision is likely to rise to 0.00 in 2024, whereas Selling General Administrative is likely to drop slightly above 48.4 M in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	35.7M	43.7M	29.5M	16.8M
Interest Income	297K	1.4M	3.8M	3.4M

Depreciation And Amortization Interest Income

Cardlytics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets
Total Assets		0.77	0.97	0.96	0.95	0.69	0.32	0.68	0.91	0.11	-0.62	0.16	0.75	0.97	-0.33	-0.19	0.77	0.75	0.86	0.84	-0.54	0.71	0.32	0.82	-0.21	0.87
Short Long Term Debt Total	0.77		0.76	0.73	0.64	0.2	0.52	0.5	0.69	0.46	-0.81	0.07	0.64	0.7	-0.31	-0.06	1.0	0.64	0.85	0.87	-0.63	0.93	0.58	0.82	-0.21	0.76
Other Current Liab	0.97	0.76		0.99	0.9	0.62	0.33	0.55	0.92	0.22	-0.68	0.23	0.63	0.98	-0.36	-0.32	0.76	0.63	0.87	0.84	-0.5	0.71	0.33	0.83	-0.23	0.86
Total Current Liabilities	0.96	0.73	0.99		0.87	0.64	0.27	0.52	0.93	0.21	-0.64	0.35	0.6	0.98	-0.45	-0.41	0.71	0.6	0.82	0.78	-0.39	0.66	0.34	0.79	-0.29	0.81
Total Stockholder Equity	0.95	0.64	0.9	0.87		0.66	0.43	0.77	0.84	-0.08	-0.54	0.0	0.8	0.88	-0.21	-0.06	0.64	0.8	0.85	0.81	-0.58	0.6	0.02	0.79	-0.15	0.91
Other Liab	0.69	0.2	0.62	0.64	0.66		-0.38	0.42	0.62	-0.24	0.05	0.23	0.39	0.76	-0.08	-0.14	0.19	0.39	0.28	0.25	-0.18	0.12	0.25	0.24	0.01	0.34
Net Tangible Assets	0.32	0.52	0.33	0.27	0.43	-0.38		0.42	0.27	0.25	-0.76	-0.35	0.49	0.16	-0.07	0.15	0.54	0.49	0.71	0.71	-0.55	0.62	-0.25	0.72	-0.09	0.7
Property Plant And Equipment Net	0.68	0.5	0.55	0.52	0.77	0.42	0.42		0.43	-0.39	-0.28	-0.23	0.98	0.51	-0.25	0.27	0.49	0.98	0.59	0.58	-0.42	0.47	-0.04	0.52	-0.28	0.69
Current Deferred Revenue	0.91	0.69	0.92	0.93	0.84	0.62	0.27	0.43		0.27	-0.65	0.36	0.5	0.94	-0.44	-0.48	0.69	0.5	0.82	0.77	-0.41	0.63	0.31	0.8	-0.35	0.75
Net Debt	0.11	0.46	0.22	0.21	-0.08	-0.24	0.25	-0.39	0.27		-0.69	0.29	-0.27	0.2	-0.18	-0.44	0.47	-0.27	0.28	0.3	-0.17	0.61	0.56	0.47	-0.03	0.1
Retained Earnings	-0.62	-0.81	-0.68	-0.64	-0.54	0.05	-0.76	-0.28	-0.65	-0.69		-0.04	-0.41	-0.58	0.28	0.24	-0.83	-0.41	-0.85	-0.87	0.57	-0.91	-0.33	-0.94	0.16	-0.75
Accounts Payable	0.16	0.07	0.23	0.35	0.0	0.23	-0.35	-0.23	0.36	0.29	-0.04		-0.24	0.31	-0.75	-0.86	0.0	-0.24	-0.08	-0.1	0.63	-0.03	0.34	0.03	-0.48	-0.19
Cash	0.75	0.64	0.63	0.6	0.8	0.39	0.49	0.98	0.5	-0.27	-0.41	-0.24		0.57	-0.24	0.27	0.64	1.0	0.7	0.71	-0.53	0.6	0.08	0.62	-0.25	0.78
Non Current Assets Total	0.97	0.7	0.98	0.98	0.88	0.76	0.16	0.51	0.94	0.2	-0.58	0.31	0.57		-0.35	-0.35	0.69	0.57	0.78	0.75	-0.44	0.64	0.39	0.76	-0.19	0.77
Non Currrent Assets Other	-0.33	-0.31	-0.36	-0.45	-0.21	-0.08	-0.07	-0.25	-0.44	-0.18	0.28	-0.75	-0.24	-0.35		0.76	-0.24	-0.24	-0.21	-0.18	-0.44	-0.26	-0.29	-0.3	0.89	-0.13
Other Assets	-0.19	-0.06	-0.32	-0.41	-0.06	-0.14	0.15	0.27	-0.48	-0.44	0.24	-0.86	0.27	-0.35	0.76		-0.01	0.27	-0.07	-0.02	-0.48	-0.07	-0.23	-0.21	0.62	0.04
Long Term Debt	0.77	1.0	0.76	0.71	0.64	0.19	0.54	0.49	0.69	0.47	-0.83	0.0	0.64	0.69	-0.24	-0.01		0.64	0.87	0.89	-0.69	0.93	0.55	0.83	-0.16	0.78
Cash And Short Term Investments	0.75	0.64	0.63	0.6	0.8	0.39	0.49	0.98	0.5	-0.27	-0.41	-0.24	1.0	0.57	-0.24	0.27	0.64		0.7	0.71	-0.53	0.6	0.08	0.62	-0.25	0.78
Net Receivables	0.86	0.85	0.87	0.82	0.85	0.28	0.71	0.59	0.82	0.28	-0.85	-0.08	0.7	0.78	-0.21	-0.07	0.87	0.7		0.99	-0.73	0.83	0.19	0.94	-0.15	0.97
Common Stock Shares Outstanding	0.84	0.87	0.84	0.78	0.81	0.25	0.71	0.58	0.77	0.3	-0.87	-0.1	0.71	0.75	-0.18	-0.02	0.89	0.71	0.99		-0.73	0.85	0.24	0.93	-0.1	0.94
Short Term Investments	-0.54	-0.63	-0.5	-0.39	-0.58	-0.18	-0.55	-0.42	-0.41	-0.17	0.57	0.63	-0.53	-0.44	-0.44	-0.48	-0.69	-0.53	-0.73	-0.73		-0.65	-0.1	-0.63	-0.32	-0.74
Long Term Debt Total	0.71	0.93	0.71	0.66	0.6	0.12	0.62	0.47	0.63	0.61	-0.91	-0.03	0.6	0.64	-0.26	-0.07	0.93	0.6	0.83	0.85	-0.65		0.53	0.9	-0.16	0.74
Non Current Liabilities Total	0.32	0.58	0.33	0.34	0.02	0.25	-0.25	-0.04	0.31	0.56	-0.33	0.34	0.08	0.39	-0.29	-0.23	0.55	0.08	0.19	0.24	-0.1	0.53		0.23	-0.15	0.03
Capital Surpluse	0.82	0.82	0.83	0.79	0.79	0.24	0.72	0.52	0.8	0.47	-0.94	0.03	0.62	0.76	-0.3	-0.21	0.83	0.62	0.94	0.93	-0.63	0.9	0.23		-0.18	0.89
Inventory	-0.21	-0.21	-0.23	-0.29	-0.15	0.01	-0.09	-0.28	-0.35	-0.03	0.16	-0.48	-0.25	-0.19	0.89	0.62	-0.16	-0.25	-0.15	-0.1	-0.32	-0.16	-0.15	-0.18		-0.1
Other Current Assets	0.87	0.76	0.86	0.81	0.91	0.34	0.7	0.69	0.75	0.1	-0.75	-0.19	0.78	0.77	-0.13	0.04	0.78	0.78	0.97	0.94	-0.74	0.74	0.03	0.89	-0.1

Click cells to compare fundamentals

Cardlytics Account Relationship Matchups

Cardlytics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	224.3M	422.5M	1.3B	691.2M	574.1M	440.0M
Short Long Term Debt Total	37K	188.1M	197.2M	235.3M	266.1M	138.7M
Other Current Liab	76.0M	74.8M	313.4M	238.5M	162.2M	126.0M
Total Current Liabilities	78.4M	81.3M	327.4M	248.9M	171.1M	135.4M
Total Stockholder Equity	143.3M	157.2M	690.7M	211.6M	134.8M	98.0M
Other Liab	2.6M	679K	54.5M	334K	384.1K	364.9K
Net Tangible Assets	139.1M	150.4M	(190.5M)	158.1M	181.8M	190.9M
Property Plant And Equipment Net	14.3M	24.6M	21.5M	12.5M	10.6M	14.5M
Current Deferred Revenue	1.1M	349K	3.3M	1.8M	2.4M	1.3M
Net Debt	(104.4M)	(105.1M)	(36.2M)	113.4M	174.3M	183.0M
Retained Earnings	(338.6M)	(394.1M)	(522.6M)	(976.6M)	(1.1B)	(1.1B)
Accounts Payable	1.2M	1.4M	4.6M	3.8M	4.4M	3.2M
Cash	104.5M	293.2M	233.5M	121.9M	91.8M	116.8M
Non Current Assets Total	28.6M	36.9M	905.1M	441.2M	350.2M	226.1M
Non Currrent Assets Other	10.1M	5.6M	2.4M	2.6M	2.7M	2.6M
Other Assets	10.1M	22.6M	2.4M	2.6M	2.3M	2.2M
Long Term Debt	13K	174.0M	184.4M	226.0M	257.6M	130.8M
Cash And Short Term Investments	104.5M	293.2M	233.5M	121.9M	91.8M	116.8M
Net Receivables	85.4M	86.6M	117.2M	120.1M	126.0M	89.2M
Common Stock Shares Outstanding	23.7M	27.2M	32.2M	33.4M	36.5M	26.9M
Long Term Debt Total	13K	174.0M	184.4M	226.0M	260.0M	273.0M
Liabilities And Stockholders Equity	224.3M	422.5M	1.3B	691.2M	574.1M	440.0M
Non Current Liabilities Total	2.6M	184.1M	245.7M	230.7M	268.2M	206.5M
Capital Surpluse	480.6M	551.4M	1.2B	1.2B	1.4B	1.4B
Inventory	129K	110K	95K	80K	72K	68.4K
Other Current Assets	5.8M	5.7M	8.0M	8.0M	6.1M	5.2M
Other Stockholder Equity	480.6M	551.4M	1.2B	1.2B	1.2B	628.4M
Total Liab	81.0M	265.3M	573.1M	479.6M	439.3M	342.0M
Deferred Long Term Liab	8.5M	3.8M	139K	198K	178.2K	169.3K
Property Plant And Equipment Gross	14.3M	24.6M	11.3M	5.9M	43.7M	45.9M
Total Current Assets	195.7M	385.6M	358.7M	250.0M	223.9M	213.8M
Accumulated Other Comprehensive Income	1.3M	(192K)	486K	5.6M	2.5M	1.9M
Short Term Debt	24K	4.7M	6.0M	4.9M	2.1M	3.6M
Intangible Assets	4.2M	6.7M	138.7M	73.4M	59.6M	35.1M
Property Plant Equipment	14.3M	13.9M	21.5M	5.9M	6.8M	12.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

VTSNX	Vanguard Total International
VBTIX	Vanguard Total Bond
VMCIX	Vanguard Mid Cap Index

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cardlytics Ev To Operating Cash Flow vs Invested Capital Analysis

Ev To Operating Cash Flow vs Invested Capital

Ev To Operating Cash Flow vs Invested Capital Correlation Analysis

Correlation Coefficient

Ev To Operating Cash Flow

Invested Capital

Cardlytics fundamental ratios Correlations

Cardlytics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cardlytics fundamental ratios Accounts

Also Currently Popular

Additional Tools for Cardlytics Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Total Current Liabilities	+ 0.99	Other Current Liab
Common Stock Shares Outstanding	+ 0.99	Net Receivables
Non Current Assets Total	+ 0.98	Other Current Liab
Non Current Assets Total	+ 0.98	Total Current Liabilities

Capital Surpluse	- 0.94	Retained Earnings
Long Term Debt Total	- 0.91	Retained Earnings
Common Stock Shares Outstanding	- 0.87	Retained Earnings
Other Assets	- 0.86	Accounts Payable
Net Receivables	- 0.85	Retained Earnings
Long Term Debt	- 0.83	Retained Earnings